Contrasting levels of p21ras activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid
- 1 May 1998
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 157 (2) , 129-137
- https://doi.org/10.1016/s0022-510x(98)00083-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Activation of p21ras by nerve growth factor in neuroblastoma cellsJournal of the Neurological Sciences, 1995
- Changing expression of GTPase activating proteins with differentiation in neuroblastomaJournal of the Neurological Sciences, 1994
- Differential regulation of cellular activities by GTPase-activating protein and NF1.Molecular and Cellular Biology, 1993
- Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosisCell, 1992
- Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patientsNature, 1992
- Identification and characterization of the neurofibromatosis type 1 protein product.Proceedings of the National Academy of Sciences, 1991
- Incidence of ras gene mutations in neuroblastomaEuropean Journal of Pediatrics, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae.Molecular and Cellular Biology, 1987
- Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiationCell, 1985